Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells

Japanese Journal of Cancer Research

Volumn 92, Issue 2, 2001, Pages 152-160

  Sugimoto, Tohru ^a   Kuroda, Hiroshi ^b   Horii, Yoshihiro ^b   Moritake, Hiroshi ^b   Tanaka, Takeo ^c   Hattori, Seisuke ^d  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c National Hospital Organization   (Japan)

^d NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Neuroblastoma; Neurotrophins; Signal transduction; TRK A; TRK B

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COLLAGEN; GUANOSINE TRIPHOSPHATE; K 252A; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NEUROTROPHIN 4; NEUROTROPIN; PHOSPHOLIPASE C; PROTEIN C FOS; PROTEIN INHIBITOR; PROTEIN SHC; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RAS PROTEIN; TYROSINE KINASE RECEPTOR;

ADRENAL TUMOR; ANIMAL CELL; ARTICLE; CASE REPORT; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NEUROTROPISM; NONHUMAN; ONCOGENE C FOS; ONCOGENE RAS; ONCOGENE SRC; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RAT; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ADRENAL GLAND NEOPLASMS; ANIMALS; CARBAZOLES; CELL DIFFERENTIATION; CELL SURVIVAL; CHILD, PRESCHOOL; ENZYME INHIBITORS; HUMANS; KINETICS; MALE; NERVE GROWTH FACTORS; NEUROBLASTOMA; PC12 CELLS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; RECEPTOR, TRKA; RECEPTOR, TRKB; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0035087114     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2001.tb01077.x     Document Type: Article

References (35)

1. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma
2. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastoma
3. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis
4. Prognostic discrimination among neuroblastomas according to Ha-ras/trk A gene expression
5. Expression and function of TRK-B and BDNF in human neuroblastomas
6. Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2)
7. Identical expression of cell surface membrane antigens on two parent and eighteen cloned cell lines derived from two different neuroblastoma metastases of the same patient
8. Alpha-smooth-muscle actin and desmin expressions in human neuroblastoma cell lines
9. Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8)
10. Nerve growth factor induces rapid accumulation of the GTP-bound form of p21ras in rat pheochromocytoma PC12 cells
11. Monoclonal antibody highly sensitive for the detection of ras p21 in immunoblotting analysis
12. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors
13. Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras
14. Involvement of prolonged Ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor dependent hematopoietic cell line
15. Morphological differentiation of human neuroblastoma cell lines by a new synthetic polyprenoic acid (E5166)
16. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability
17. A water-soluble tetrazolium salt useful for colorimetric cell viability assay
18. High-level expression in Escherichia coli of enzymatically active Harvey murine sarcoma virus p21ras protein
19. The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor
20. Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells
21. The Trk family of neurotrophin receptors
22. Neurotrophin signal transduction by the Trk receptor
23. Developmental changes in NT3 signalling via TrkA and TrkB in embryonic neurons
24. Trk receptors use redundant signal transduction pathways involving SHC and PLC-γ1 to mediate NGF responses
25. Constitutive phosphorylation of TrkC receptors in cultured cerebellar granule neurons might be responsible for the inability of NT-3 to increase neuronal survival and to activate p21 Ras
26. Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in response to brain-derived neurotrophic factor in cultured cerebral cortical neurons
27. Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells
28. Frequent detection of TrkA expression in human neuroblastoma cell lines
29. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity
30. Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cells
31. Selective regulation of TrkA and TrkB receptors by retinoic acid and interferon-γ in human neuroblastoma cell lines
32. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells
33. Brain-derived neurotrophic factor promotes survival and chemo-protection of human neuroblastoma cells
34. Increased expression of trk proto-oncogene by γ-interferon in human neuroblastoma cell lines
35. Ras-regulated hypophosphorylation of the retinoblastoma protein mediates neuronal differentiation in PC12 cells